Significant Increases in Borrow Rates Among Liquid Option Names
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 2d ago
0mins
Should l Buy ADUR?
Latest data shows the largest indicative borrow rate increases among liquid option names include: Aduro Clean Technologies Inc. (ADUR) 14.54% +2.62, PureCycle Technologies (PCT) 16.70% +1.63, EETH ETF (EETH) 16.25% +0.86, Canopy Growth (CGC) 44.76% +0.63, DIREXION DAILY META BULL 2X SHARES (METU) 20.61% +0.61, LendingClub (LC) 0.97% +0.59, CrowdGather Inc (CRWG) 11.09% +0.37, Tradr 2X Long IREN Daily ETF (IREX) 20.92% +0.37, Tradr 2X Long SNDK Daily ETF (SNXX) 10.76% +0.30, and VIX ShortTerm Futures ETN (VXX) 3.17% +0.26.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ADUR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ADUR
About ADUR
Aduro Clean Technologies Inc. is a Canada-based clean technology company. The Company is a developer of water-based technologies to chemically recycle waste plastics; convert heavy crude and bitumen into lighter, more valuable oil, and transform renewable oils into higher-value fuels or renewable chemicals. Its chemical recycling platform features three water-based technologies, such as Hydrochemolytic Plastics Upcycling (HPU), Hydrochemolytic Renewables Upgrading (HRU) and Hydrochemolytic Bitumen Upgrading (HBU). Its Plastics Upcycling application converts waste plastics into feedstocks for producing new plastics or hydrocarbon fuels. Its HRU transform renewable oils into renewable motor fuels, sustainable aviation fuel (SAF), and specialty chemicals in scalable formats that can be integrated straightforwardly into existing operations.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Aduro Selects Netherlands for First Industrial Facility
- Site Selection: Aduro Clean Technologies has chosen Chemelot Industrial Park in Sittard-Geleen, Netherlands, for its first industrial-scale facility, marking a crucial transition from pilot work to commercial operations, which is expected to significantly enhance its market position in plastic recycling.
- Technological Innovation: The facility will utilize Aduro's Hydrochemolytic technology to chemically recycle waste plastics into higher-value products, with an initial processing capacity of 10,000 tonnes per year and potential for phased expansion as operations stabilize, driving future growth.
- Infrastructure Advantages: Chemelot offers shared utilities, centralized wastewater treatment, and established safety and permitting frameworks, reducing development friction for industrial projects and ensuring smooth implementation of Aduro's expansion plans.
- Financial Performance: Aduro's recent earnings report indicates a 222% year-over-year revenue increase to CAD 122,706 for the second fiscal quarter, although wider losses were reported due to increased spending related to scaling up, reflecting financial pressures during rapid expansion.
See More
Aduro Clean Technologies Reports Q2 Loss of C$0.21 per Share Despite 200% Revenue Growth
- Earnings Report: Aduro Clean Technologies reported a Q2 GAAP loss of C$0.21 per share, missing expectations by C$0.09, indicating ongoing challenges in achieving profitability.
- Revenue Surge: Despite the loss, the company achieved revenue of C$0.12 million, reflecting a remarkable 200% year-over-year growth, showcasing strong potential in the clean technology sector.
- Funding Initiative: The company has announced a C$20 million underwritten public offering aimed at providing financial support for future expansion and R&D, thereby enhancing its competitive position in the market.
- Market Sentiment: Although revenue has significantly increased, investor concerns regarding the ongoing losses may pressure the stock price, leading to a cautious market sentiment.
See More
Aduro Clean Technologies (ADUR) Shares Drop 4.11% Amid Bear Cave Report Questioning Stock Surge
- Stock Price Decline: Aduro Clean Technologies' shares fell 4.11% to $13.99 on Thursday morning, primarily influenced by a Bear Cave report that characterized the company's 200% stock surge as driven by aggressive stock promotion rather than fundamental improvements.
- Revenue vs. Losses: Despite the significant stock increase since its NASDAQ listing in November, Aduro generated only about $200,000 in revenue over the past year against $11 million in losses, highlighting the fragility of its business model.
- Impact of Marketing Activities: The Bear Cave report emphasizes that Aduro's retail popularity is largely fueled by extensive paid marketing campaigns rather than substantive business progress, with the company engaging multiple investor relations firms to enhance digital marketing and social media awareness.
- Scrutiny of Partnerships: The report further questions Aduro's commercial relationships, noting its reliance on “letters of intent” instead of definitive agreements; although the CEO mentioned a “commercial agreement” with Shell, Aduro clarified to the SEC that its participation in the Shell GameChanger program was solely for technology evaluation without ongoing commitments.
See More
Aduro Clean Technologies Reports 222% Revenue Increase to CAD 122,706 in Q2
- Significant Revenue Growth: Aduro Clean Technologies reported Q2 revenue of CAD 122,706, marking a 222% increase from CAD 38,143 in Q2 2025, indicating strong performance amid rising market demand.
- Increased Operating Loss: The company experienced an operating loss of CAD 6.46 million in Q2 2026, up from CAD 3.11 million in Q2 2025, reflecting cost pressures faced during its expansion phase.
- Public Offering Initiative: Aduro Clean Technologies is pursuing a CAD 20 million underwritten public offering aimed at financing future R&D and market expansion, thereby enhancing its financial flexibility.
- Cautious Market Outlook: Despite the significant revenue increase, analysts remain cautious about the company's future performance, awaiting more data to assess its long-term profitability and market competitiveness.
See More
Bank of America (BAC) Expected to Report Q4 Earnings of $0.97 on $27.65 Billion Revenue
- Investment Banking Fee Rebound: A 42% year-over-year surge in global M&A activity is expected to drive a rebound in investment banking fees for major banks, indicating a resurgence in market vitality that could positively impact profitability for BAC and others.
- BAC Earnings Expectations: Bank of America is set to release its fourth-quarter earnings on Wednesday, with analysts forecasting earnings of $0.97 per share and quarterly revenue of $27.65 billion, reflecting the company's stable performance amid economic recovery.
- Market Focus on CEO Commentary: Investors will closely watch CEO Brian Moynihan's comments, particularly regarding the resilience of the U.S. consumer and assessments of global geopolitical risks, which could influence market sentiment and investment decisions.
- Kickoff of Major Bank Earnings Season: This week marks the official kickoff of the major bank earnings season, with JPMorgan Chase, Wells Fargo, and others set to report, and the market will closely monitor these reports for their impact on the overall financial market.
See More
Altimmune Inc Receives FDA Breakthrough Therapy Designation for Pemvidutide, Shares Surge 23.6%
- FDA Certification Impact: Altimmune Inc's Pemvidutide received FDA Breakthrough Therapy Designation, leading to a 23.6% surge in shares to $4.34 on Monday, indicating strong market confidence in its potential efficacy and possibly accelerating its path to market.
- Clinical Progress: GH Research PLC's GH001 lifted from FDA clinical hold saw shares rise 33.8% to $17.72, reflecting significant advancements in drug development that are expected to enhance its competitive position in the market.
- Executive Change: Rayonier Advanced Materials Inc appointed Scott M. Sutton as the new CEO, resulting in a 14.1% increase in shares to $6.68, suggesting that this leadership change could bring new strategic directions and growth opportunities for the company.
- Market Rebound: The overall market showed strong performance with the S&P 500 index rising, reflecting investor optimism about economic recovery, which may drive more capital inflows into the stock market.
See More
Aduro Selects Netherlands for First Industrial Facility
- Site Selection: Aduro Clean Technologies has chosen Chemelot Industrial Park in Sittard-Geleen, Netherlands, for its first industrial-scale facility, marking a crucial transition from pilot work to commercial operations, which is expected to significantly enhance its market position in plastic recycling.
- Technological Innovation: The facility will utilize Aduro's Hydrochemolytic technology to chemically recycle waste plastics into higher-value products, with an initial processing capacity of 10,000 tonnes per year and potential for phased expansion as operations stabilize, driving future growth.
- Infrastructure Advantages: Chemelot offers shared utilities, centralized wastewater treatment, and established safety and permitting frameworks, reducing development friction for industrial projects and ensuring smooth implementation of Aduro's expansion plans.
- Financial Performance: Aduro's recent earnings report indicates a 222% year-over-year revenue increase to CAD 122,706 for the second fiscal quarter, although wider losses were reported due to increased spending related to scaling up, reflecting financial pressures during rapid expansion.
See More
Aduro Clean Technologies Reports Q2 Loss of C$0.21 per Share Despite 200% Revenue Growth
- Earnings Report: Aduro Clean Technologies reported a Q2 GAAP loss of C$0.21 per share, missing expectations by C$0.09, indicating ongoing challenges in achieving profitability.
- Revenue Surge: Despite the loss, the company achieved revenue of C$0.12 million, reflecting a remarkable 200% year-over-year growth, showcasing strong potential in the clean technology sector.
- Funding Initiative: The company has announced a C$20 million underwritten public offering aimed at providing financial support for future expansion and R&D, thereby enhancing its competitive position in the market.
- Market Sentiment: Although revenue has significantly increased, investor concerns regarding the ongoing losses may pressure the stock price, leading to a cautious market sentiment.
See More
Aduro Clean Technologies (ADUR) Shares Drop 4.11% Amid Bear Cave Report Questioning Stock Surge
- Stock Price Decline: Aduro Clean Technologies' shares fell 4.11% to $13.99 on Thursday morning, primarily influenced by a Bear Cave report that characterized the company's 200% stock surge as driven by aggressive stock promotion rather than fundamental improvements.
- Revenue vs. Losses: Despite the significant stock increase since its NASDAQ listing in November, Aduro generated only about $200,000 in revenue over the past year against $11 million in losses, highlighting the fragility of its business model.
- Impact of Marketing Activities: The Bear Cave report emphasizes that Aduro's retail popularity is largely fueled by extensive paid marketing campaigns rather than substantive business progress, with the company engaging multiple investor relations firms to enhance digital marketing and social media awareness.
- Scrutiny of Partnerships: The report further questions Aduro's commercial relationships, noting its reliance on “letters of intent” instead of definitive agreements; although the CEO mentioned a “commercial agreement” with Shell, Aduro clarified to the SEC that its participation in the Shell GameChanger program was solely for technology evaluation without ongoing commitments.
See More
Aduro Clean Technologies Reports 222% Revenue Increase to CAD 122,706 in Q2
- Significant Revenue Growth: Aduro Clean Technologies reported Q2 revenue of CAD 122,706, marking a 222% increase from CAD 38,143 in Q2 2025, indicating strong performance amid rising market demand.
- Increased Operating Loss: The company experienced an operating loss of CAD 6.46 million in Q2 2026, up from CAD 3.11 million in Q2 2025, reflecting cost pressures faced during its expansion phase.
- Public Offering Initiative: Aduro Clean Technologies is pursuing a CAD 20 million underwritten public offering aimed at financing future R&D and market expansion, thereby enhancing its financial flexibility.
- Cautious Market Outlook: Despite the significant revenue increase, analysts remain cautious about the company's future performance, awaiting more data to assess its long-term profitability and market competitiveness.
See More
Bank of America (BAC) Expected to Report Q4 Earnings of $0.97 on $27.65 Billion Revenue
- Investment Banking Fee Rebound: A 42% year-over-year surge in global M&A activity is expected to drive a rebound in investment banking fees for major banks, indicating a resurgence in market vitality that could positively impact profitability for BAC and others.
- BAC Earnings Expectations: Bank of America is set to release its fourth-quarter earnings on Wednesday, with analysts forecasting earnings of $0.97 per share and quarterly revenue of $27.65 billion, reflecting the company's stable performance amid economic recovery.
- Market Focus on CEO Commentary: Investors will closely watch CEO Brian Moynihan's comments, particularly regarding the resilience of the U.S. consumer and assessments of global geopolitical risks, which could influence market sentiment and investment decisions.
- Kickoff of Major Bank Earnings Season: This week marks the official kickoff of the major bank earnings season, with JPMorgan Chase, Wells Fargo, and others set to report, and the market will closely monitor these reports for their impact on the overall financial market.
See More
Altimmune Inc Receives FDA Breakthrough Therapy Designation for Pemvidutide, Shares Surge 23.6%
- FDA Certification Impact: Altimmune Inc's Pemvidutide received FDA Breakthrough Therapy Designation, leading to a 23.6% surge in shares to $4.34 on Monday, indicating strong market confidence in its potential efficacy and possibly accelerating its path to market.
- Clinical Progress: GH Research PLC's GH001 lifted from FDA clinical hold saw shares rise 33.8% to $17.72, reflecting significant advancements in drug development that are expected to enhance its competitive position in the market.
- Executive Change: Rayonier Advanced Materials Inc appointed Scott M. Sutton as the new CEO, resulting in a 14.1% increase in shares to $6.68, suggesting that this leadership change could bring new strategic directions and growth opportunities for the company.
- Market Rebound: The overall market showed strong performance with the S&P 500 index rising, reflecting investor optimism about economic recovery, which may drive more capital inflows into the stock market.
See More
